- Home
- INM vs KRMD Comparison
INM vs KRMD Comparison
Compare INM & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- KRMD
- Stock Information
- Founded
- INM 1981
- KRMD 1980
- Country
- INM Canada
- KRMD United States
- Employees
- INM N/A
- KRMD 80
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- INM Health Care
- KRMD Health Care
- Exchange
- INM Nasdaq
- KRMD Nasdaq
- Market Cap
- INM N/A
- KRMD 113.5M
- IPO Year
- INM N/A
- KRMD N/A
- Fundamental
- Price
- INM $2.72
- KRMD $2.27
- Analyst Decision
- INM
- KRMD Strong Buy
- Analyst Count
- INM 0
- KRMD 4
- Target Price
- INM N/A
- KRMD $4.88
- AVG Volume (30 Days)
- INM 38.9K
- KRMD 152.8K
- Earning Date
- INM 05-13-2025
- KRMD 05-07-2025
- Dividend Yield
- INM N/A
- KRMD N/A
- EPS Growth
- INM N/A
- KRMD N/A
- EPS
- INM N/A
- KRMD N/A
- Revenue
- INM $4,832,013.00
- KRMD $33,646,463.00
- Revenue This Year
- INM N/A
- KRMD $16.50
- Revenue Next Year
- INM N/A
- KRMD $15.47
- P/E Ratio
- INM N/A
- KRMD N/A
- Revenue Growth
- INM N/A
- KRMD 17.98
- 52 Week Low
- INM $1.72
- KRMD $1.86
- 52 Week High
- INM $15.70
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- INM 54.51
- KRMD 35.61
- Support Level
- INM $2.37
- KRMD $1.86
- Resistance Level
- INM $2.79
- KRMD $2.53
- Average True Range (ATR)
- INM 0.24
- KRMD 0.21
- MACD
- INM 0.09
- KRMD 0.04
- Stochastic Oscillator
- INM 88.14
- KRMD 51.25
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).